✦ LIBER ✦

Treatment of metastatic urothelial cancer in the post-MVAC era

✍ Scribed by Ezra E. W. Cohen; Walter M. Stadler

Book ID: 106033683
Publisher: Springer-Verlag
Year: 2001
Tongue: English
Weight: 91 KB
Volume: 19
Category: Article
ISSN: 0724-4983
DOI: 10.1007/s003450000193

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New drugs and new approaches for the tre

New drugs and new approaches for the treatment of metastatic urothelial cancer

✍ Fabio Calabrò; Cora N. Sternberg 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 111 KB

Controversies in the treatment of metast

Controversies in the treatment of metastatic prostate cancer

✍ David G. McLeod; E. David Crawford; Brent A. Blumenstein; Mario A. Eisenberger; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

Herceptin in the treatment of metastatic

Herceptin in the treatment of metastatic breast cancer

✍ G. Konecny; M. Untch; M. Pegram 📂 Article 📅 1999 🏛 Springer 🌐 German ⚖ 120 KB

Treatment of Metastatic Colorectal Cance

Treatment of Metastatic Colorectal Cancer in the Elderly

✍ Hong L. Nguyen; Jimmy Hwang 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 166 KB

Oral medroxyprogesterone in the treatmen

Oral medroxyprogesterone in the treatment of metastatic breast cancer

✍ Takuma Nemoto; Jashbha1 Patel; Dutzu Rosner; Thomas L. Dao 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

In 47 postmenopausal women with evaluable breast cancer, oral medroxyprogesterone acetate (MPA) was given at a daily dose level of 400 mg. Patients with negative estrogen receptors, poor performance status , or nonresponse to previous endocrine therapy were excluded from this study. There were 25 (

Oral medroxyprogesterone acetate in the

Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer

✍ Gabriel N. Hortobagyi; Aman U. Buzdar; Debra Frye; Hwee-Yong Yap; Verena Hug; Ka 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 464 KB